Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1547PDF: 878HTML: 980figures: 178table 1: 181table2: 180table3: 181 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
840PDF: 486HTML: 1303 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3771PDF: 1483HTML: 485Figures . Eliassian: 222 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
940PDF: 573HTML: 2193Cover Letter: 190 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
970PDF: 533HTML: 722 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3919Suppl. Files: 1115PDF: 1066Html: 176 -
IMMUNOLOGY OF TUBERCULOSIS
5294PDF: 2002HTML: 7319Untitled: 195 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1940PDF: 1164HTML: 266 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1379PDF: 1306HTML: 99 -
-
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3032PDF: 1024HTML: 3078 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1166PDF: 824HTML: 2183Figue 1: 173 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3686PDF: 1236HTML: 3889Untitled: 211Untitled: 258 -
-
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1750PDF: 531HTML: 16970Figure 4: 166Figure 3: 140Figure 2: 145Figure 1: 177 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3298PDF: 1342HTML: 2625 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4798PDF: 1787HTML: 2705Untitled: 215 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3315PDF: 1316HTML: 6191 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1160PDF: 914HTML: 288 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1297PDF: 1008HTML: 122 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3270PDF: 1238HTML: 8105 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1621PDF: 796HTML: 860jdoe, table 2 infections CML .doc: 194jdoe, table 1 infections CML .doc: 181 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1388PDF: 818HTML: 3123 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4102PDF: 1587HTML: 952 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1851PDF: 1050HTML: 253







